- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 8 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
K.3: 6 residues within 4Å:- Chain A: N.52, S.54, D.84, T.85, S.212, K.239
No protein-ligand interaction detected (PLIP)K.4: 2 residues within 4Å:- Chain A: E.241, D.265
No protein-ligand interaction detected (PLIP)K.8: 2 residues within 4Å:- Chain B: E.241, D.265
No protein-ligand interaction detected (PLIP)K.9: 4 residues within 4Å:- Chain B: Q.355, S.356, L.358, E.360
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:L.358
K.13: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)K.14: 3 residues within 4Å:- Chain C: Q.355, L.358, E.360
No protein-ligand interaction detected (PLIP)K.17: 6 residues within 4Å:- Chain D: N.52, S.54, D.84, T.85, S.212, K.239
No protein-ligand interaction detected (PLIP)K.18: 4 residues within 4Å:- Chain D: Q.355, S.356, L.358, E.360
No protein-ligand interaction detected (PLIP)- 5 x QV7: 3-hydroxy-4-[(E)-{2-sulfo-4-[(E)-(4-sulfophenyl)diazenyl]phenyl}diazenyl]naphthalene-2,7-disulfonic acid(Non-covalent)
QV7.5: 6 residues within 4Å:- Chain A: P.30, H.55, G.56, S.57, Y.60, K.336
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:Y.60, A:Y.60
- Hydrogen bonds: A:S.57, A:S.57
- Water bridges: A:G.56
- Salt bridges: A:H.55, A:K.336
- pi-Stacking: A:H.55
QV7.6: 4 residues within 4Å:- Chain B: S.54, H.55, G.56, K.336
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:H.55
- Hydrogen bonds: B:G.56
- Water bridges: B:K.336
- Salt bridges: B:K.336
QV7.10: 6 residues within 4Å:- Chain C: T.403, R.405, D.483, H.484, V.486, K.487
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:H.484, C:V.486
- Hydrogen bonds: C:D.483, C:H.484, C:K.487, C:K.487
- Water bridges: C:R.405, C:R.405, C:R.405
- Salt bridges: C:H.484, C:K.487, C:K.487
QV7.12: 10 residues within 4Å:- Chain A: S.2, V.362, N.365, K.369
- Chain B: S.2
- Chain C: S.2, Y.361, V.362, N.365
- Ligands: QV7.15
7 PLIP interactions:2 interactions with chain B, 3 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: B:S.2, A:S.2, A:K.369, C:S.2
- Water bridges: B:S.2
- Hydrophobic interactions: A:K.369, C:Y.361
QV7.15: 11 residues within 4Å:- Chain B: S.2, Y.361, V.362, N.365
- Chain C: S.2
- Chain D: S.2, Y.361, V.362, N.365, K.369
- Ligands: QV7.12
8 PLIP interactions:3 interactions with chain B, 3 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: B:Y.361
- Hydrogen bonds: B:S.2, B:V.362, D:S.2, D:N.365, D:K.369, C:S.2
- Water bridges: C:S.2
- 1 x QV8: 9,10-dioxo-4-(phenylamino)-9,10-dihydroanthracene-2-sulfonic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgan, H.P. et al., The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site. J.Biol.Chem. (2011)
- Release Date
- 2011-06-29
- Peptides
- Pyruvate kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
AC
BD
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 8 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
- 5 x QV7: 3-hydroxy-4-[(E)-{2-sulfo-4-[(E)-(4-sulfophenyl)diazenyl]phenyl}diazenyl]naphthalene-2,7-disulfonic acid(Non-covalent)
- 1 x QV8: 9,10-dioxo-4-(phenylamino)-9,10-dihydroanthracene-2-sulfonic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Morgan, H.P. et al., The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site. J.Biol.Chem. (2011)
- Release Date
- 2011-06-29
- Peptides
- Pyruvate kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
AC
BD
C